KaydedilenlerDerginizi ekleyin

Dergiler / Gülhane Tıp Dergisi / 2018 / Cilt: 60 - Sayı: 1

Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?

MURAT ZOR
ENGİN KAYA
SELAHATTİN BEDİR
Sayfa
14–18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: Demonstrating the greatest diagnostic accuracy of PSAD in prostates ≥60 and <80 cc makes an invaluable contribution to the current literature and would be a reference point for further studies.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: We aimed to evaluate whether there is a specific subgroup of patients who benefit most from PSAD screening according to their prostate volume.
📊
Temel Bulgular & Veri:Results: Of 326 patients 98 (30.0%) had pCa.
💡
Sonuç & Katkı:Conclusions: Demonstrating the greatest diagnostic accuracy of PSAD in prostates ≥60 and <80 cc makes an invaluable contribution to the current literature and would be a reference point for further studies.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aims: We aimed to evaluate whether there is a specific subgroup of patients who benefit most from PSAD screening according to their prostate volume. Methods: Transrectal ultrasound guided prostate biopsy performed patients were stratified in five groups according to their prostate size. PSAD values were compared between groups, and the diagnostic accuracy of PSAD was evaluated for different prostate volumes. Results: Of 326 patients 98 (30.0%) had pCa. While total PSA and PSAD between pCa(+) and (-) patients were significantly higher in group 1,2 and 3, the differences was not significant in group 4 and 5. The highest AUC value was achieved for group 3 and the lowest for group 5. The optimal cutoff values were different between groups. Conclusions: Demonstrating the greatest diagnostic accuracy of PSAD in prostates ≥60 and <80 cc makes an invaluable contribution to the current literature and would be a reference point for further studies.

🔖

Bu Makaleye Atıf Yap

ZOR, M., KAYA, E., BEDİR, S. (2018). Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?. Gülhane Tıp Dergisi, Cilt: 60 - Sayı: 1, 14–18. https://ajindex.com/articles/165006

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Tosoian J, Loeb S. PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer. Scientific World Journal. 2010;10:1919-1931.
  2. Chen CS, Wang SS, Li JR, et al. PSA density as a better predictor of prostate cancer than percent-free PSA in a repeat biopsy. J Chin Med Assoc. 2011;74(12):552-555.
  3. Bazinet M, Meshref AW, Trudel C, et al. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology. 1994;43(1):44-51; discussion 51-52.
  4. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC. PSA density (PSAD). Role in patient evaluation and management. Urol Clin North Am. 1993;20(4):653-663.
  5. Di Donna A, Bazzocchi M, Guerra UP, et al. The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma: a comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy. Radiol Med 1993;85:84e9. Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J Urol. 1998;160(1):77-81.
  6. Adhyam M, Gupta AK. A Review on the Clinical Utility of PSA in Cancer Prostate. Indian J Surg Oncol. 2012;3(2):120-129.
  7. Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147(3 Pt 2):815-816.
  8. Andriole GL, Telle WB, Coplen DE, Catalona WJ. PSA index (PSAI) as a predictor of prostate cancer in men with persis- tent serum PSA elevation (abstract). J Urol 1992;147:387A Rommel FM, Agusta VE, Breslin JA, et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol. 1994;151:88–93.
  9. Catalona WJ, Richie JP, deKernion JB, et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2031.
  10. Ciatto S, Bonardi R, Lombardi C, et al. Predicting prostate biopsy outcome by findings at digital rectal examination, transrectal ultrasonography, PSA, PSA density and free-to-total PSA ratio in a population-based screening setting. Int J Biol Markers. 2001;16:179–182.
  11. Ohori M, Dunn JK, Scardino PT. Is pros